(Q44580927)

English

Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift? (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

5

1 reference

Europe PubMed Central

4 December 2017

author name string

Laura Caberlotto

1

1 reference

Europe PubMed Central

4 December 2017

Roberto Rimondini

2

1 reference

Europe PubMed Central

4 December 2017

Anita Hansson

3

1 reference

Europe PubMed Central

4 December 2017

Siv Eriksson

4

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

4 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

4 December 2017

29

1 reference

Europe PubMed Central

4 December 2017

1

1 reference

Europe PubMed Central

4 December 2017

15-22

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300296

0 references

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Neuropeptide Y mRNA regulation in rat sympathetic ganglia: effect of reserpine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Cannabinoid receptor localization in brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Stress, corticotropin-releasing factor, and drug addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Drug addiction, dysregulation of reward, and allostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Neuronal localisation of neuropeptide Y gene expression in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

A review of the published literature into cannabis withdrawal symptoms in human users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Differential impairments of selective attention due to frequency and duration of cannabis use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

21 January 2018

Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

7 January 2021

based on heuristic

inferred from DOI database lookup

Internalization and Recycling of the CB1 Cannabinoid Receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

7 January 2021

based on heuristic

inferred from DOI database lookup

Hu 210: a potent tool for investigations of the cannabinoid system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300296

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300296

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44580927&oldid=1466183709"